{"entity":{"type":"insider","cik":"0001866154","url":"/insider/0001866154","json_url":"/insider/0001866154.json","name":"Hill Stephen J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2025-08-13","last":"2026-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Hill Stephen J.","source":"filing","n_filings":8,"first_seen":"2025-08-13","last_seen":"2026-08-25"}],"transactions":[{"id":9301113,"accession":"0001866154-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001866154-26-000006","line_url":"/filing/0001866154-26-000006#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":989.0,"shares_display":"989","price_per_share":15.54,"price_display":"15.54","price_state":"stated","total_value":15369.06,"total_display":"15,369.06","total_whole":"15,369","shares_owned_after":16816.0,"shares_owned_after_display":"16,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-25","scope":"insider"},{"id":9296566,"accession":"0001866154-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001866154-26-000004","line_url":"/filing/0001866154-26-000004#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89.0,"shares_display":"89","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":1276.26,"total_display":"1,276.26","total_whole":"1,276","shares_owned_after":17805.0,"shares_owned_after_display":"17,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":6160350,"accession":"0001866154-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001866154-26-000003","line_url":"/filing/0001866154-26-000003#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89.0,"shares_display":"89","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":1683.88,"total_display":"1,683.88","total_whole":"1,684","shares_owned_after":17894.0,"shares_owned_after_display":"17,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-06-15","scope":"insider"},{"id":6181326,"accession":"0001866154-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001866154-26-000002","line_url":"/filing/0001866154-26-000002#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1236.0,"shares_display":"1,236","price_per_share":23.39,"price_display":"23.39","price_state":"stated","total_value":28910.04,"total_display":"28,910.04","total_whole":"28,910","shares_owned_after":17795.0,"shares_owned_after_display":"17,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":5841309,"accession":"0001866154-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001866154-26-000001","line_url":"/filing/0001866154-26-000001#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109.0,"shares_display":"109","price_per_share":23.12,"price_display":"23.12","price_state":"stated","total_value":2520.08,"total_display":"2,520.08","total_whole":"2,520","shares_owned_after":19031.0,"shares_owned_after_display":"19,031","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":4285514,"accession":"0001866154-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001866154-25-000006","line_url":"/filing/0001866154-25-000006#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95.0,"shares_display":"95","price_per_share":16.12,"price_display":"16.12","price_state":"stated","total_value":1531.4,"total_display":"1,531.40","total_whole":"1,531","shares_owned_after":15750.0,"shares_owned_after_display":"15,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4054979,"accession":"0001415889-25-022746","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022746","line_url":"/filing/0001415889-25-022746#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1004.0,"shares_display":"1,004","price_per_share":10.544,"price_display":"10.54","price_state":"stated","total_value":10586.176,"total_display":"10,586.18","total_whole":"10,586","shares_owned_after":15845.0,"shares_owned_after_display":"15,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":4320489,"accession":"0001415889-25-021693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021693","line_url":"/filing/0001415889-25-021693#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":10.338,"price_display":"10.34","price_state":"stated","total_value":971.772,"total_display":"971.77","total_whole":"972","shares_owned_after":8849.0,"shares_owned_after_display":"8,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4320485,"accession":"0001415889-25-021693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021693","line_url":"/filing/0001415889-25-021693#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001866154","owner_name":"Hill Stephen J.","owner_display_name":"Hill Stephen J.","owner_url":"/insider/0001866154","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91.0,"shares_display":"91","price_per_share":10.526,"price_display":"10.53","price_state":"stated","total_value":957.866,"total_display":"957.87","total_whole":"958","shares_owned_after":8943.0,"shares_owned_after_display":"8,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Officer (Chief Operating Officer)","n_filings":8,"first_seen":"2025-08-13","last_seen":"2026-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001866154","retrieved_at":"2026-08-27T05:04:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}